Ads
related to: psoriasis- Treatment Option
Get Info On Treatment
Option. Learn More Today.
- Treatment Support
See Treatment Support Resources For
Questions About Costs, Dosing, etc.
- Dosing Timeline
Learn About a Dosing Schedule
and Administration Options.
- Share Your Story
Your Personal Health Journey
Can Inspire and Help Others.
- Get Personalized Emails
Complete Form to Receive
Personalized Resources.
- Insurance Coverage
Learn About Insurance Coverage &
Patient Support.
- Treatment Option
Search results
StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)
ETF DAILY NEWS· 3 days agoStock analysts at StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a research report issued on Friday. The brokerage set a “hold” rating on the ...
AbbVie (NYSE:ABBV) Shares Down 0.1%
ETF DAILY NEWS· 4 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price dropped 0.1% during mid-day trading on Thursday . The stock traded as low as $157.76 and last traded at $159.38. Approximately 903,885 ...
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Dai ichi Life Insurance Company Ltd
ETF DAILY NEWS· 5 days agoDai ichi Life Insurance Company Ltd lessened its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 47.1% during the fourth quarter, according to its most recent disclosure with ...
Swiss National Bank Cuts Stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
ETF DAILY NEWS· 4 days agoSwiss National Bank trimmed its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 9.8% in the 4th quarter, according to the company in its most recent Form ...
Comprehensive Dermatology and Radio Frequency Treatment in Abu Dhabi
Digital Journal· 6 days agoAbu Dhabi is a premier destination for advanced dermatological care and cutting-edge treatments. Whether you are looking for comprehensive dermatology services or the latest in aesthetic treatments ...
Robeco Institutional Asset Management B.V. Sells 180,219 Shares of Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 4 days agoRobeco Institutional Asset Management B.V. trimmed its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 52.7% in the 4th quarter, according to its most recent 13F filing with the Securities ...
UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in...
WKRN Nashville· 6 days agoUCB, a global biopharmaceutical company, today announced that The Lancet has published results from the Phase 3 BE HEARD I and BE HEARD II trials evaluating the efficacy and safety of BIMZELX ...
Biogen Inc. (NASDAQ:BIIB) Shares Sold by PNC Financial Services Group Inc.
ETF DAILY NEWS· 5 days agoPNC Financial Services Group Inc. reduced its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 3.0% during the 4th quarter, according to the company in its most recent filing with the SEC ...
Needham & Company LLC Reiterates “Buy” Rating for Biogen (NASDAQ:BIIB)
ETF DAILY NEWS· 5 days agoBiogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a report issued on Wednesday, Benzinga reports. Needham & Company LLC’s price objective ...
Johnson & Johnson pushes for empowering IBD patients in China
China Daily· 5 days agoJohnson & Johnson is set to intensify patient education efforts in China to better address the unmet needs of inflammatory bowel disease (IBD) patients. IBD is a chronic condition involving ...
Ads
related to: psoriasis